Target
Free fatty acid receptor 1
Ligand
BDBM300840
Substrate
n/a
Meas. Tech.
GPR40 Calcium Flux Assay
EC50
19.0±n/a nM
Citation
 Huang, HKuo, GPlayer, MRYang, SZhang, Y Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes US Patent  US10131648 Publication Date 11/20/2018 
Target
Name:
Free fatty acid receptor 1
Synonyms:
FFAR1 | FFAR1_HUMAN | G-protein Coupled Receptor 40 | GPR40
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
31473.32
Organism:
Homo sapiens (Human)
Description:
O14842
Residue:
300
Sequence:
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK
  
Inhibitor
Name:
BDBM300840
Synonyms:
2-(1-(4-((3-(2-Methylpyridin-3- yl)benzo[b]thiophen-5- yl)methoxy)phenyl)-3- oxocyclobutyl)acetic acid | US10131648, Compound 38 | US10195178, Compound 38 | US9790198, Compound 38
Type:
Small organic molecule
Emp. Form.:
C27H23NO4S
Mol. Mass.:
457.541
SMILES:
Cc1ncccc1-c1csc2ccc(COc3ccc(cc3)C3(CC(O)=O)CC(=O)C3)cc12
Structure:
Search PDB for entries with ligand similarity: